Uniogen’s unique glycovariant immunoassay technology is based on nanoparticles coated with carbohydrate group-specific binders at a high density, translating to an improved sensitivity and specificity compared to conventional assays. We’re currently developing our first proprietary test for the early detection of ovarian cancer and hold patents for detection of a variety of cancer types.

GenomEra® CDX system by Uniogen is a powerful tool for running molecular diagnostics routinely and cost-efficiently—with zero compromises in assay reliability or quality. Our current offering of CE-marked GenomEra IVD tests covers ten different assay kits for the detection of different infectious agents, including SARS-CoV-2.

Uniogen is a specialist provider of ready-to-use reagents, components, and individualized assay development services for high-quality IVD immunoassays and antibody tests. Our wide array of available custom assay services includes kit manufacturing, plate production, biomolecule conjugation, and buffer preparation—all adaptable for your specific needs.